Skip to content
Riskpilot
← Back to search
Sign in
Get full access
LOXiPharm IVS
IVS
Bankrupt
Advertising protection
CVR 39889846
Ordrupvej 132C, 2920
Charlottenlund
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2018 · 7 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
LOXiPharm IVS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
0M
-1M
-1M
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
Income statement
DKK thousands
Item
Gross profit
Staff expenses
EBITDA
Depreciation & amort.
EBIT
Net financials
Profit before tax
Tax
Net profit
Balance sheet
DKK thousands
Item
Total assets
Equity
Long-term debt
Short-term debt
Total debt
Financial ratios
5-year trend
EBITDA margin (of gross profit)
%
This company
Equity ratio
%
This company
38.2%
Market median
Return on equity
%
This company
18.4%
Market median
Net profit margin (of gross profit)
%
This company
Asset turnover (of gross profit)
×
This company
Debt / equity
×
This company
0.62×
Market median
Annual reports & filings
More on LOXiPharm IVS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
